,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Anaemia,1,16353705
1,22.0,Second primary malignancy,1,16353705
2,22.0,Diarrhoea,1,16353705
3,22.0,Myelodysplastic syndrome,1,16353705
4,22.0,Thrombocytosis,1,16353705
5,22.0,Neoplasm progression,2,16353705
0,22.0,Death,5,16353744
0,22.0,Lung infection,5,16353745
1,22.0,Dyspnoea,5,16353745
0,22.0,Vasculitis,1,16353788
0,22.1,Hair colour changes,3,16353804
1,22.1,Depression,6,16353804
2,22.1,Stress,6,16353804
3,22.1,Hair disorder,3,16353804
4,22.1,Alopecia,3,16353804
5,22.1,Hair texture abnormal,3,16353804
6,22.1,Madarosis,3,16353804
0,22.0,Chest pain,2,16353813
0,22.0,Renal aneurysm,6,16353844
1,22.0,Aortic aneurysm,6,16353844
2,22.0,Emphysema,6,16353844
3,22.0,Brain neoplasm,1,16353844
4,22.0,Pneumothorax,2,16353844
5,22.0,Pneumothorax,1,16353844
6,22.0,Procedural complication,6,16353844
7,22.0,Peripheral artery aneurysm,6,16353844
0,22.1,Pneumonia,1,16353863
0,22.0,Nausea,6,16353881
1,22.0,Fatigue,6,16353881
2,22.0,Dyspnoea,6,16353881
0,22.0,Renal injury,3,16353885
0,22.0,Deep vein thrombosis,1,16353896
1,22.0,Pulmonary embolism,1,16353896
0,22.0,Breast cancer,6,16353910
0,22.0,Anaemia,6,16353933
0,22.0,Anaemia,6,16353955
1,22.0,Decreased appetite,1,16353955
2,22.0,Haemoglobin decreased,1,16353955
3,22.0,Metastases to liver,6,16353955
4,22.0,Malaise,1,16353955
5,22.0,Febrile neutropenia,1,16353955
0,22.0,Death,5,16353959
0,22.0,Diarrhoea,6,16353968
1,22.0,Hepatic neoplasm,6,16353968
2,22.0,Gait disturbance,6,16353968
3,22.0,General physical health deterioration,6,16353968
4,22.0,Skin lesion,6,16353968
5,22.0,Dizziness,6,16353968
6,22.0,Fatigue,6,16353968
7,22.0,Depression,6,16353968
8,22.0,Alopecia,6,16353968
9,22.0,Bone pain,6,16353968
10,22.0,Malaise,6,16353968
11,22.0,Headache,6,16353968
0,22.0,Product use in unapproved indication,6,16354004
1,22.0,Toxicity to various agents,6,16354004
2,22.0,Pancreatitis,2,16354004
0,22.0,Malaise,1,16354038
1,22.0,Hypertension,1,16354038
2,22.0,Interstitial lung disease,3,16354038
0,22.0,Death,5,16354073
1,22.0,Tumour marker increased,6,16354073
2,22.0,Neoplasm progression,6,16354073
3,22.0,General physical health deterioration,6,16354073
0,22.0,Vomiting,4,16354081
1,22.0,Fall,4,16354081
2,22.0,Vertigo,4,16354081
0,22.0,Fall,6,16354141
1,22.0,Blood glucose abnormal,6,16354141
2,22.0,Chronic obstructive pulmonary disease,6,16354141
3,22.0,Fatigue,6,16354141
4,22.0,Product dose omission,6,16354141
0,22.0,Intestinal obstruction,1,16354158
0,22.0,Red blood cell count decreased,3,16354163
1,22.0,Headache,3,16354163
2,22.0,Malaise,3,16354163
3,22.0,Dry mouth,3,16354163
4,22.0,White blood cell count decreased,3,16354163
5,22.0,Contusion,3,16354163
6,22.0,Dyspepsia,3,16354163
7,22.0,Haematocrit decreased,3,16354163
8,22.0,Haemoglobin decreased,3,16354163
9,22.0,Hypoaesthesia,3,16354163
10,22.0,Neutropenia,3,16354163
11,22.0,Nausea,3,16354163
12,22.0,Anaemia,3,16354163
13,22.0,Vomiting,3,16354163
14,22.0,Dizziness,3,16354163
15,22.0,Constipation,3,16354163
16,22.0,Prostatic specific antigen abnormal,3,16354163
17,22.0,Fatigue,3,16354163
0,22.0,Myocardial infarction,5,16354202
0,22.0,Embolism,5,16354210
0,22.0,Aphthous ulcer,6,16354246
1,22.0,Febrile neutropenia,1,16354246
2,22.0,Mucosal inflammation,1,16354246
3,22.0,Diarrhoea,1,16354246
4,22.0,Asthenia,1,16354246
5,22.0,Malaise,1,16354246
6,22.0,Fatigue,1,16354246
0,22.0,Blood alkaline phosphatase increased,1,16354330
0,22.1,Neutropenia,6,16354354
1,22.1,Haemorrhoidal haemorrhage,6,16354354
2,22.1,Hypertension,6,16354354
3,22.1,Thrombocytopenia,6,16354354
4,22.1,Proteinuria,6,16354354
0,22.0,Urinary retention,2,16354359
1,22.0,Benign prostatic hyperplasia,3,16354359
0,22.0,Bone marrow failure,2,16354360
1,22.0,Diarrhoea,2,16354360
0,22.1,Hypoaesthesia,1,16354364
1,22.1,Paraesthesia,1,16354364
2,22.1,Polyneuropathy,1,16354364
0,22.1,Nephrolithiasis,6,16354371
1,22.1,Acne,2,16354371
2,22.1,Dry skin,6,16354371
3,22.1,Dizziness,2,16354371
4,22.1,Nausea,2,16354371
5,22.1,Hyperhidrosis,2,16354371
6,22.1,Diarrhoea,2,16354371
7,22.1,Hypothyroidism,6,16354371
8,22.1,Pruritus,6,16354371
9,22.1,Thyroid cancer,6,16354371
10,22.1,Thyroid neoplasm,6,16354371
11,22.1,Vomiting,6,16354371
12,22.1,Malaise,1,16354371
13,22.1,Syncope,2,16354371
14,22.1,Muscle spasms,6,16354371
0,22.0,Alanine aminotransferase increased,1,16354414
1,22.0,Aspartate aminotransferase increased,1,16354414
2,22.0,Liver disorder,1,16354414
3,22.0,Jaundice,1,16354414
4,22.0,Blood bilirubin increased,1,16354414
5,22.0,Blood alkaline phosphatase increased,1,16354414
6,22.0,Blood lactate dehydrogenase increased,1,16354414
7,22.0,Gamma-glutamyltransferase increased,6,16354414
0,22.0,Breast cancer,6,16354419
1,22.0,Metastases to soft tissue,6,16354419
2,22.0,Metastases to bone,6,16354419
3,22.0,Drug ineffective,6,16354419
4,22.0,Metastases to lung,6,16354419
5,22.0,Metastasis,6,16354419
6,22.0,Malignant neoplasm progression,6,16354419
7,22.0,Infection,6,16354419
0,22.0,Liver injury,6,16354423
1,22.0,Oropharyngeal pain,1,16354423
2,22.0,Hypertension,6,16354423
3,22.0,Malaise,6,16354423
4,22.0,Nausea,1,16354423
5,22.0,Cough,1,16354423
6,22.0,Vomiting,1,16354423
7,22.0,Pain,2,16354423
0,22.0,Interstitial lung disease,2,16354438
0,22.0,Radiation pneumonitis,1,16354489
0,22.0,Hepatocellular injury,1,16354515
1,22.0,Hepatitis,1,16354515
0,22.0,Hypotension,3,16354519
1,22.0,Diarrhoea,3,16354519
2,22.0,Hypoglycaemia,3,16354519
3,22.0,Mineral metabolism disorder,3,16354519
4,22.0,Renal failure,3,16354519
0,22.0,Faecaloma,1,16354539
1,22.0,Pelvic abscess,1,16354539
2,22.0,Rectal abscess,1,16354539
3,22.0,Rectal stenosis,1,16354539
4,22.0,Subileus,1,16354539
5,22.0,Renal failure,1,16354539
6,22.0,Oedema peripheral,1,16354539
7,22.0,Diarrhoea,1,16354539
0,22.0,Pneumonia,5,16354592
0,22.0,Muscular weakness,6,16354633
1,22.0,Death,5,16354633
2,22.0,Diarrhoea,6,16354633
3,22.0,Dehydration,6,16354633
4,22.0,Hiccups,6,16354633
0,22.0,Retinal artery embolism,1,16354683
1,22.0,Neutrophil count decreased,1,16354683
2,22.0,Malignant neoplasm progression,6,16354683
3,22.0,Metastases to bone,6,16354683
4,22.0,Visual field defect,1,16354683
0,22.0,Hypoxic-ischaemic encephalopathy,5,16354728
1,22.0,Decreased appetite,6,16354728
2,22.0,Cardiac arrest,5,16354728
3,22.0,Interstitial lung disease,5,16354728
4,22.0,Acute respiratory distress syndrome,5,16354728
5,22.0,Headache,6,16354728
0,22.0,Off label use,3,16354755
1,22.0,Neurotoxicity,6,16354755
0,22.1,Hypokalaemia,1,16354859
1,22.1,Blood creatinine increased,1,16354859
2,22.1,Blood bilirubin increased,3,16354859
3,22.1,Fatigue,3,16354859
0,22.0,Abdominal sepsis,1,16354868
0,22.0,Lower limb fracture,2,16354913
0,22.0,Vascular device infection,1,16354925
0,22.0,Peripheral swelling,6,16354927
0,22.0,Arthritis,3,16354930
0,22.0,Tendon rupture,6,16354957
0,22.0,Enterocolitis haemorrhagic,1,16354990
0,22.0,Pneumonia,5,16354992
1,22.0,Adrenal insufficiency,6,16354992
0,22.0,Product dose omission,6,16355040
1,22.0,Product availability issue,6,16355040
2,22.0,No adverse event,6,16355040
0,22.0,Arthralgia,3,16355086
1,22.0,Malaise,3,16355086
2,22.0,Dysstasia,3,16355086
3,22.0,Weight decreased,3,16355086
4,22.0,Decreased appetite,3,16355086
5,22.0,Musculoskeletal pain,3,16355086
6,22.0,Back pain,3,16355086
7,22.0,Chest pain,3,16355086
0,22.0,Nausea,1,16355099
1,22.0,Diarrhoea,1,16355099
0,22.0,Carotid artery dissection,2,16355130
0,22.0,Febrile neutropenia,1,16355234
1,22.0,Pneumonia,1,16355234
0,22.0,Bone marrow failure,2,16355237
1,22.0,Decreased appetite,2,16355237
2,22.0,Asthenia,2,16355237
3,22.0,Nausea,2,16355237
4,22.0,Vomiting,1,16355237
0,22.0,Dyspnoea,3,16355244
1,22.0,Ejection fraction decreased,3,16355244
2,22.0,Cardiotoxicity,3,16355244
0,22.0,Dysphagia,6,16355316
1,22.0,Product size issue,6,16355316
0,22.0,Chills,1,16355320
1,22.0,Pyrexia,1,16355320
2,22.0,Inflammation,2,16355320
0,22.0,Diarrhoea,1,16355326
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16355326
2,22.0,Neuropathy peripheral,6,16355326
3,22.0,Cardio-respiratory arrest,6,16355326
4,22.0,Diarrhoea,5,16355326
0,22.1,Immune-mediated adverse reaction,5,16355346
1,22.1,Hepatic failure,5,16355346
2,22.1,Off label use,6,16355346
3,22.1,Bone marrow failure,1,16355346
4,22.1,Renal failure,5,16355346
5,22.1,Pyrexia,3,16355346
6,22.1,C-reactive protein increased,3,16355346
7,22.1,Decreased appetite,3,16355346
0,22.0,White blood cell count decreased,6,16355381
1,22.0,Off label use,6,16355381
2,22.0,Intentional product use issue,6,16355381
0,22.0,Rhabdomyolysis,6,16355420
1,22.0,Cardiomyopathy,6,16355420
2,22.0,Intentional product use issue,6,16355420
0,22.0,Tendon rupture,4,16355525
0,22.0,Syncope,6,16355530
1,22.0,Posterior reversible encephalopathy syndrome,2,16355530
2,22.0,Confusional state,6,16355530
0,22.0,Lung adenocarcinoma,6,16355534
1,22.0,Abdominal pain,6,16355534
2,22.0,Pulmonary mass,6,16355534
3,22.0,Pleural effusion,6,16355534
4,22.0,Small intestinal obstruction,6,16355534
5,22.0,Ovarian enlargement,6,16355534
6,22.0,Palpitations,6,16355534
7,22.0,Oedema,6,16355534
8,22.0,Cytopenia,6,16355534
9,22.0,Breast cancer metastatic,6,16355534
10,22.0,Metastases to liver,6,16355534
11,22.0,Musculoskeletal pain,6,16355534
12,22.0,Atrial flutter,6,16355534
13,22.0,Bone pain,6,16355534
14,22.0,Malignant ascites,6,16355534
15,22.0,Metastases to bone,6,16355534
16,22.0,Malignant neoplasm progression,6,16355534
17,22.0,Weight increased,6,16355534
0,22.0,Death,5,16355566
0,22.0,Chills,3,16355575
1,22.0,Rash erythematous,3,16355575
0,22.0,Product dose omission,6,16355579
1,22.0,No adverse event,6,16355579
0,22.0,Urosepsis,6,16355690
1,22.0,Arthritis,2,16355690
2,22.0,Febrile neutropenia,1,16355690
0,22.0,Hepatic enzyme increased,1,16355715
1,22.0,Palpitations,1,16355715
2,22.0,Fatigue,1,16355715
3,22.0,Neutropenia,1,16355715
4,22.0,Gastrointestinal disorder,1,16355715
0,22.0,Rash generalised,6,16355743
1,22.0,Liver disorder,6,16355743
2,22.0,Decreased appetite,6,16355743
3,22.0,Renal disorder,6,16355743
0,22.1,Malignant neoplasm progression,5,16355780
1,22.1,Subclavian vein thrombosis,6,16355780
0,22.0,Death,5,16355803
0,22.0,Epilepsy,1,16355805
1,22.0,Hyponatraemia,1,16355805
0,22.1,Chest discomfort,1,16355811
1,22.1,Chest pain,1,16355811
2,22.1,Cough,3,16355811
3,22.1,Product use in unapproved indication,6,16355811
4,22.1,Muscle spasms,1,16355811
5,22.1,Laboratory test abnormal,6,16355811
6,22.1,Asthma,3,16355811
7,22.1,Dehydration,6,16355811
8,22.1,Dyspnoea,3,16355811
9,22.1,Hypersensitivity,6,16355811
10,22.1,Nausea,1,16355811
11,22.1,Malaise,3,16355811
12,22.1,Myalgia,3,16355811
13,22.1,Headache,1,16355811
14,22.1,Constipation,6,16355811
15,22.1,Off label use,6,16355811
16,22.1,Pneumonia,3,16355811
17,22.1,Nasopharyngitis,6,16355811
18,22.1,Carbohydrate antigen 125 increased,3,16355811
19,22.1,Recurrent cancer,6,16355811
20,22.1,Vomiting,6,16355811
0,22.0,Hot flush,6,16355845
0,22.0,Prostatic specific antigen increased,3,16355846
1,22.0,Drug ineffective,6,16355846
0,22.0,Arrhythmia,6,16355868
1,22.0,Thyroid hormones increased,6,16355868
0,22.0,Coagulopathy,6,16355869
1,22.0,Fatigue,6,16355869
2,22.0,Atrial fibrillation,6,16355869
3,22.0,Blood pressure increased,6,16355869
4,22.0,Mobility decreased,6,16355869
5,22.0,Glossodynia,6,16355869
6,22.0,Arthralgia,6,16355869
7,22.0,Stomatitis,6,16355869
8,22.0,Dysphonia,6,16355869
9,22.0,Nausea,6,16355869
10,22.0,Gingival pain,6,16355869
0,22.0,Cough,6,16355993
1,22.0,Oxygen saturation decreased,6,16355993
2,22.0,Productive cough,6,16355993
0,22.0,Leukocytosis,1,16356045
1,22.0,Vomiting,1,16356045
2,22.0,Malaise,1,16356045
3,22.0,Pyrexia,1,16356045
4,22.0,Thrombocytopenia,1,16356045
0,22.0,Therapeutic product effect decreased,3,16356059
0,22.0,Malignant neoplasm progression,5,16356159
0,22.0,Cholecystitis,3,16356207
0,22.0,Death,5,16356214
1,22.0,Product use in unapproved indication,6,16356214
0,22.0,Intentional product use issue,6,16356215
1,22.0,Malignant neoplasm progression,5,16356215
0,22.0,Hypophagia,1,16356251
0,22.0,Vomiting,1,16356278
0,22.0,Hypertransaminasaemia,6,16356316
0,22.0,Disease progression,6,16356381
1,22.0,Rash,6,16356381
0,22.0,Diverticulitis,6,16356383
1,22.0,Off label use,6,16356383
2,22.0,Fistula,6,16356383
3,22.0,Intentional product use issue,6,16356383
0,22.0,Atrial fibrillation,3,16356412
0,22.0,Hepatic enzyme increased,2,16356428
0,22.0,Lymphocyte count decreased,2,16356431
0,22.0,Pneumonia,3,16356452
1,22.0,Immune-mediated hepatitis,3,16356452
0,22.0,Metastatic neoplasm,6,16356503
1,22.0,Immune system disorder,6,16356503
0,22.0,Renal impairment,6,16356512
0,22.0,Posterior reversible encephalopathy syndrome,2,16356538
0,22.0,Pruritus,1,16356548
1,22.0,Erythema,1,16356548
0,22.0,Hypotension,2,16356549
1,22.0,Band sensation,2,16356549
0,22.0,Toxicity to various agents,5,16356587
1,22.0,Death,5,16356587
2,22.0,Product use in unapproved indication,5,16356587
3,22.0,Deafness,6,16356587
0,22.0,Pleural effusion,6,16356590
0,22.1,Stoma site haemorrhage,1,16356592
1,22.1,Large intestine polyp,1,16356592
0,22.0,Acute kidney injury,2,16356601
0,22.0,Posterior reversible encephalopathy syndrome,2,16356603
0,22.1,Death,5,16356606
0,22.0,Renal impairment,6,16356640
1,22.0,Hyperglycaemic hyperosmolar nonketotic syndrome,6,16356640
2,22.0,Diabetic ketoacidosis,6,16356640
3,22.0,Fulminant type 1 diabetes mellitus,4,16356640
0,22.0,Chest pain,1,16356646
0,22.0,Death,5,16356677
0,22.0,Intestinal obstruction,6,16356684
0,22.0,Ileus,6,16356690
0,22.0,Agranulocytosis,1,16356725
1,22.0,Leukopenia,1,16356725
0,22.0,Neutropenia,3,16356729
1,22.0,Thrombocytopenia,3,16356729
2,22.0,Anaemia,3,16356729
0,22.0,Renal failure,3,16356730
0,22.0,Toxic skin eruption,2,16356739
0,22.0,Diarrhoea,3,16356743
1,22.0,Asthenia,3,16356743
0,22.1,Fulminant type 1 diabetes mellitus,6,16356783
1,22.1,Interstitial lung disease,2,16356783
2,22.1,Liver abscess,2,16356783
0,22.1,Cardiac failure,1,16356789
1,22.1,Tremor,1,16356789
2,22.1,Malignant neoplasm progression,3,16356789
3,22.1,Hypothyroidism,2,16356789
0,22.0,Stress ulcer,2,16356840
1,22.0,Bone marrow failure,6,16356840
0,22.0,Fatigue,6,16356845
1,22.0,Asthenia,6,16356845
2,22.0,Pneumonia,6,16356845
3,22.0,Diarrhoea,6,16356845
4,22.0,Dyspepsia,6,16356845
0,22.0,Infusion related reaction,1,16356849
1,22.0,Erythema,1,16356849
0,22.0,White blood cell count increased,6,16356857
1,22.0,Intentional product use issue,6,16356857
2,22.0,Pyrexia,6,16356857
3,22.0,Off label use,6,16356857
0,22.0,Infusion related reaction,1,16356899
1,22.0,Erythema,1,16356899
0,22.0,Chest pain,6,16356920
1,22.0,Pain in jaw,6,16356920
2,22.0,Dyspnoea,6,16356920
0,22.0,Vascular device infection,6,16356935
1,22.0,Gait disturbance,6,16356935
2,22.0,Mood swings,1,16356935
3,22.0,Hot flush,1,16356935
4,22.0,Restless legs syndrome,6,16356935
5,22.0,Fatigue,6,16356935
0,22.0,Cholangitis sclerosing,6,16357016
0,22.0,General physical health deterioration,6,16357111
1,22.0,Arthralgia,2,16357111
2,22.0,Dyspnoea,6,16357111
3,22.0,Device related infection,1,16357111
4,22.0,Decreased appetite,2,16357111
5,22.0,Respiratory arrest,5,16357111
6,22.0,Disorientation,6,16357111
7,22.0,Gait disturbance,2,16357111
8,22.0,Chest pain,6,16357111
9,22.0,Asthenia,2,16357111
10,22.0,Vomiting,1,16357111
11,22.0,Multiple organ dysfunction syndrome,5,16357111
12,22.0,Pain,2,16357111
13,22.0,Insomnia,2,16357111
0,22.1,Mental status changes,1,16357112
0,22.0,Insomnia,3,16357116
1,22.0,Anaemia,1,16357116
2,22.0,Platelet count decreased,1,16357116
3,22.0,Weight decreased,3,16357116
4,22.0,Neuropathy peripheral,3,16357116
5,22.0,Influenza,6,16357116
6,22.0,Sleep disorder,6,16357116
7,22.0,Fatigue,3,16357116
8,22.0,Constipation,3,16357116
9,22.0,Feeling abnormal,6,16357116
10,22.0,Dehydration,6,16357116
0,22.0,Myocardial infarction,1,16357128
0,22.0,Disorientation,6,16357139
1,22.0,C-reactive protein increased,6,16357139
0,22.0,Gastric perforation,1,16357174
1,22.0,Gastric ulcer,1,16357174
2,22.0,Peritonitis,6,16357174
0,22.0,Leukoencephalopathy,1,16357212
1,22.0,Hemiparesis,1,16357212
2,22.0,Mutism,1,16357212
0,22.0,Erythema,6,16357213
1,22.0,Laryngeal oedema,6,16357213
0,22.0,Hypersensitivity,1,16357214
1,22.0,Dyspepsia,1,16357214
0,22.0,Pneumonitis,3,16357336
0,22.0,Walking disability,6,16357361
1,22.0,Eating disorder,6,16357361
2,22.0,Asthenia,6,16357361
0,22.0,Renal impairment,6,16357370
1,22.0,Prescribed underdose,6,16357370
0,22.0,Death,5,16357374
0,22.0,Death,5,16357376
0,22.0,Dehydration,6,16357387
1,22.0,Fatigue,6,16357387
2,22.0,Urinary tract infection,6,16357387
0,22.0,Death,5,16357389
0,22.0,Feeling hot,1,16357393
1,22.0,Hypersensitivity,6,16357393
2,22.0,Tachycardia,1,16357393
3,22.0,Hyperhidrosis,1,16357393
4,22.0,Product substitution issue,6,16357393
0,22.0,Cystitis,6,16357402
1,22.0,Hot flush,6,16357402
2,22.0,Hypersensitivity,6,16357402
0,22.0,Death,5,16357411
0,22.0,Weight decreased,2,16357439
1,22.0,Influenza,2,16357439
0,22.0,Off label use,3,16357445
1,22.0,Vaginal haemorrhage,1,16357445
2,22.0,Flushing,1,16357445
0,22.0,Hypoxia,6,16357475
1,22.0,Immune-mediated pneumonitis,5,16357475
2,22.0,Rash,6,16357475
0,22.0,Acquired gene mutation,6,16357476
1,22.0,Drug resistance,6,16357476
0,22.0,BRAF gene mutation,6,16357503
1,22.0,Malignant neoplasm progression,6,16357503
2,22.0,Drug resistance,6,16357503
0,22.0,Drug resistance,6,16357524
1,22.0,BRAF gene mutation,6,16357524
2,22.0,Malignant neoplasm progression,6,16357524
0,22.0,Diarrhoea,6,16357541
0,22.0,Vomiting,6,16357581
1,22.0,Nausea,6,16357581
2,22.0,Bone marrow failure,1,16357581
3,22.0,Mucosal inflammation,1,16357581
4,22.0,Dermatitis,1,16357581
0,22.0,Circulatory collapse,6,16357588
1,22.0,Pain,6,16357588
2,22.0,Prescribed underdose,6,16357588
0,22.1,Behaviour disorder,1,16357591
1,22.1,Epilepsy,1,16357591
0,22.0,No adverse event,6,16357606
1,22.0,Product dose omission,6,16357606
0,22.0,Malignant neoplasm progression,6,16357612
1,22.0,RET gene mutation,6,16357612
2,22.0,Drug resistance,6,16357612
0,22.0,RET gene mutation,6,16357613
1,22.0,Malignant neoplasm progression,6,16357613
2,22.0,Drug resistance,6,16357613
0,22.0,Erythema,2,16357620
1,22.0,Pain in extremity,2,16357620
2,22.0,Oedema peripheral,2,16357620
0,22.0,Gamma-glutamyltransferase increased,6,16357644
1,22.0,Bile duct obstruction,2,16357644
0,22.0,Pain,6,16357648
1,22.0,Oedema peripheral,6,16357648
2,22.0,Neuropathy peripheral,6,16357648
3,22.0,Peripheral swelling,6,16357648
0,22.0,Injection site pain,3,16357679
1,22.0,Fatigue,3,16357679
2,22.0,Dyspnoea,3,16357679
0,22.1,Interstitial lung disease,4,16357696
0,22.0,Alopecia,3,16357698
0,22.0,Vomiting,2,16357706
1,22.0,Paraesthesia,2,16357706
2,22.0,Asthenia,2,16357706
3,22.0,Skin fissures,2,16357706
0,22.0,Hyperhidrosis,2,16357725
1,22.0,Nausea,2,16357725
2,22.0,Erythema,2,16357725
3,22.0,Vomiting,2,16357725
4,22.0,Abdominal pain upper,2,16357725
5,22.0,Asthenia,2,16357725
6,22.0,Flushing,2,16357725
0,22.0,Pruritus,2,16357730
1,22.0,Device related infection,2,16357730
2,22.0,Blood bilirubin increased,3,16357730
3,22.0,Staphylococcal infection,2,16357730
4,22.0,Tendonitis,3,16357730
5,22.0,Mucosal inflammation,3,16357730
6,22.0,Aspartate aminotransferase increased,3,16357730
7,22.0,Rash,2,16357730
8,22.0,Lymphocyte count decreased,3,16357730
9,22.0,Blood alkaline phosphatase increased,3,16357730
10,22.0,Chills,2,16357730
11,22.0,Purulent discharge,1,16357730
12,22.0,Device related infection,1,16357730
13,22.0,Hypoalbuminaemia,3,16357730
14,22.0,Diarrhoea,3,16357730
15,22.0,Weight decreased,3,16357730
16,22.0,Erythema,2,16357730
17,22.0,Pleural infection,2,16357730
18,22.0,Pain,2,16357730
19,22.0,Alanine aminotransferase increased,3,16357730
0,22.0,Erythema,1,16357732
1,22.0,Anxiety,1,16357732
2,22.0,Chest discomfort,1,16357732
3,22.0,Dyspnoea,1,16357732
0,22.0,Malignant neoplasm progression,6,16357750
1,22.0,Breast cancer metastatic,6,16357750
0,22.1,Neutrophil count decreased,6,16357751
1,22.1,Epigastric discomfort,1,16357751
2,22.1,Pyrexia,1,16357751
3,22.1,White blood cell count decreased,1,16357751
4,22.1,Abdominal pain upper,1,16357751
5,22.1,Basophil count decreased,6,16357751
6,22.1,Diarrhoea,1,16357751
7,22.1,Haematocrit decreased,6,16357751
8,22.1,Lymphocyte count decreased,6,16357751
0,22.1,Ocular vascular disorder,1,16357794
0,22.0,Hypertension,2,16357812
1,22.0,Transient ischaemic attack,6,16357812
2,22.0,Somnolence,6,16357812
3,22.0,Decreased appetite,2,16357812
4,22.0,Neuropathy peripheral,6,16357812
5,22.0,Taste disorder,6,16357812
6,22.0,Fatigue,3,16357812
7,22.0,Headache,3,16357812
8,22.0,Thrombocytopenia,2,16357812
0,22.0,Acquired gene mutation,6,16357827
1,22.0,Drug resistance,6,16357827
0,22.0,Oedema peripheral,6,16357828
1,22.0,Radiation pneumonitis,1,16357828
0,22.0,Pleural effusion,1,16357874
1,22.0,Pyrexia,1,16357874
0,22.0,Cystitis,6,16357905
1,22.0,Bone pain,2,16357905
2,22.0,Platelet count decreased,6,16357905
3,22.0,Blood count abnormal,6,16357905
4,22.0,Anaemia,6,16357905
5,22.0,Abdominal discomfort,1,16357905
6,22.0,Aphthous ulcer,1,16357905
0,22.0,Neutropenia,6,16357910
1,22.0,Colony stimulating factor therapy,6,16357910
0,22.0,Fatigue,6,16357960
1,22.0,Sleep disorder,6,16357960
2,22.0,Headache,6,16357960
3,22.0,Insomnia,6,16357960
4,22.0,Hot flush,6,16357960
0,22.0,Renal failure,1,16357971
1,22.0,Amylase increased,1,16357971
2,22.0,Lipase increased,1,16357971
0,22.1,Leukopenia,2,16357996
1,22.1,Anaemia,2,16357996
2,22.1,Joint swelling,6,16357996
3,22.1,Bone pain,3,16357996
4,22.1,Concomitant disease aggravated,6,16357996
5,22.1,Blood pressure increased,6,16357996
6,22.1,Fatigue,6,16357996
7,22.1,Dizziness,3,16357996
8,22.1,General physical health deterioration,1,16357996
9,22.1,Alopecia,6,16357996
10,22.1,Dyspnoea,3,16357996
0,22.0,Oral infection,5,16358020
1,22.0,Osteonecrosis of jaw,5,16358020
2,22.0,Exposed bone in jaw,5,16358020
3,22.0,Bone lesion,5,16358020
4,22.0,Jaw fistula,5,16358020
0,22.0,Burning sensation,3,16358040
1,22.0,Chest pain,3,16358040
2,22.0,Oedema peripheral,2,16358040
3,22.0,Osteoporosis,3,16358040
4,22.0,Blood cholesterol increased,3,16358040
5,22.0,Tumour marker increased,1,16358040
6,22.0,Inflammation,2,16358040
7,22.0,Concomitant disease aggravated,3,16358040
8,22.0,Nausea,3,16358040
9,22.0,Blood magnesium decreased,3,16358040
10,22.0,Blood calcium decreased,3,16358040
11,22.0,Nervousness,3,16358040
12,22.0,Drug ineffective,1,16358040
13,22.0,Abdominal pain upper,3,16358040
14,22.0,Speech disorder,3,16358040
15,22.0,Cardiac disorder,3,16358040
0,22.0,Bone pain,6,16358052
1,22.0,Presyncope,6,16358052
2,22.0,Dyspnoea exertional,6,16358052
3,22.0,Blood glucose increased,6,16358052
4,22.0,Anaemia,1,16358052
5,22.0,Arthralgia,6,16358052
6,22.0,Pain in extremity,6,16358052
7,22.0,Small intestinal haemorrhage,6,16358052
8,22.0,White blood cell count decreased,6,16358052
9,22.0,Gastric ulcer,6,16358052
10,22.0,Nausea,6,16358052
11,22.0,Thrombosis,6,16358052
12,22.0,Fatigue,6,16358052
13,22.0,Epistaxis,6,16358052
14,22.0,Blood creatinine increased,6,16358052
15,22.0,Blood magnesium increased,6,16358052
16,22.0,Joint range of motion decreased,6,16358052
17,22.0,Pulmonary thrombosis,6,16358052
18,22.0,Pulmonary haemorrhage,2,16358052
19,22.0,Blood urea increased,6,16358052
20,22.0,Haemorrhage,1,16358052
21,22.0,Metastases to bone,6,16358052
22,22.0,Vomiting,6,16358052
0,22.0,Neutropenia,1,16358068
1,22.0,Neutropenia,1,16358068
0,22.0,Bladder cancer recurrent,3,16358076
0,22.0,Small intestinal obstruction,6,16358086
1,22.0,Carbohydrate antigen 27.29 increased,6,16358086
2,22.0,Metastases to abdominal cavity,6,16358086
0,22.0,White blood cell count decreased,2,16358147
1,22.0,Malaise,2,16358147
2,22.0,Decreased immune responsiveness,6,16358147
0,22.0,Interstitial lung disease,5,16358187
0,22.1,Diverticulitis,1,16358257
1,22.1,Gastrointestinal stoma complication,1,16358257
2,22.1,Fistula,1,16358257
0,22.0,Pneumonia,5,16358268
0,22.0,Dyspnoea,6,16358269
1,22.0,Peripheral swelling,6,16358269
2,22.0,Prostate cancer,6,16358269
0,22.1,Renal impairment,2,16358272
1,22.1,Malignant ascites,5,16358272
2,22.1,Anaemia,1,16358272
3,22.1,Ileus,1,16358272
0,22.0,Liver disorder,1,16358275
1,22.0,Immune-mediated adverse reaction,1,16358275
2,22.0,Neurological symptom,1,16358275
0,22.1,Intentional product use issue,6,16358292
1,22.1,Death,5,16358292
0,22.0,Product use in unapproved indication,6,16358294
1,22.0,Death,5,16358294
0,22.0,Dementia,6,16358311
0,22.0,Haemoptysis,3,16358312
1,22.0,Asthenia,3,16358312
2,22.0,Epistaxis,3,16358312
3,22.0,Bone pain,3,16358312
4,22.0,Arthralgia,3,16358312
5,22.0,Decreased appetite,3,16358312
6,22.0,Bronchitis,3,16358312
7,22.0,Alopecia,3,16358312
8,22.0,Neuropathy peripheral,3,16358312
0,22.0,Drug ineffective for unapproved indication,6,16358343
0,22.0,Neutropenic colitis,2,16358352
0,22.0,Pneumonia,5,16358386
1,22.0,Malignant neoplasm progression,5,16358386
0,22.1,Fatigue,3,16358413
1,22.1,Dry skin,3,16358413
2,22.1,Diarrhoea,3,16358413
3,22.1,Rash,3,16358413
0,22.1,Intentional product use issue,6,16358419
1,22.1,Immune-mediated enterocolitis,1,16358419
0,22.0,Haemorrhage intracranial,6,16358439
0,22.1,Immune-mediated adverse reaction,6,16358445
1,22.1,Respiratory failure,5,16358445
2,22.1,Malignant neoplasm progression,5,16358445
3,22.1,Bronchopulmonary aspergillosis,3,16358445
4,22.1,Radiation pneumonitis,5,16358445
5,22.1,Lung disorder,5,16358445
6,22.1,Disseminated intravascular coagulation,6,16358445
7,22.1,Pulmonary necrosis,5,16358445
0,22.0,Death,5,16358457
0,22.0,Blindness,2,16358474
1,22.0,Spinal osteoarthritis,2,16358474
2,22.0,Nausea,1,16358474
3,22.0,Headache,1,16358474
0,22.0,Liver injury,6,16358501
0,22.0,Mucosal inflammation,6,16358551
1,22.0,Oral pain,1,16358551
2,22.0,Ulcer haemorrhage,6,16358551
3,22.0,Stomatitis,1,16358551
0,22.0,Burning sensation,6,16358563
1,22.0,Erythema of eyelid,6,16358563
2,22.0,Rash macular,3,16358563
3,22.0,Rash,6,16358563
0,22.0,Neuropathy peripheral,1,16358592
1,22.0,Rash,1,16358592
0,22.0,White blood cell count decreased,1,16358595
1,22.0,Platelet count decreased,1,16358595
2,22.0,Neutrophil count decreased,1,16358595
0,22.0,Cystoid macular oedema,2,16358599
0,22.0,Lethargy,6,16358606
1,22.0,Colitis,6,16358606
2,22.0,Death,5,16358606
3,22.0,Renal failure,6,16358606
4,22.0,Fatigue,6,16358606
5,22.0,Hypotension,6,16358606
6,22.0,Blister,6,16358606
7,22.0,White blood cell count increased,6,16358606
8,22.0,Dyspnoea,6,16358606
9,22.0,Chills,6,16358606
0,22.1,Urinary retention,3,16358628
1,22.1,Tumour associated fever,1,16358628
2,22.1,Kidney infection,1,16358628
3,22.1,Cerebral infarction,2,16358628
0,22.0,Haematoma,6,16358646
1,22.0,Hypoaesthesia,3,16358646
2,22.0,Dysgeusia,3,16358646
3,22.0,Seborrhoeic keratosis,3,16358646
4,22.0,Fatigue,3,16358646
5,22.0,Melanocytic naevus,3,16358646
0,22.0,Cerebral haemorrhage,6,16358681
1,22.0,Movement disorder,6,16358681
2,22.0,Speech disorder,6,16358681
0,22.1,Malignant neoplasm progression,5,16358686
1,22.1,Reexpansion pulmonary oedema,1,16358686
2,22.1,Diarrhoea,1,16358686
3,22.1,Interstitial lung disease,2,16358686
4,22.1,Cell marker increased,6,16358686
5,22.1,Neutropenia,1,16358686
6,22.1,Lung opacity,1,16358686
0,22.0,Neoplasm recurrence,5,16358691
1,22.0,Arterial haemorrhage,5,16358691
2,22.0,General physical health deterioration,5,16358691
0,22.0,Neutrophil count decreased,1,16358693
1,22.0,Platelet count decreased,1,16358693
2,22.0,Interstitial lung disease,1,16358693
3,22.0,Diarrhoea,2,16358693
4,22.0,Decreased appetite,6,16358693
5,22.0,Red blood cell count decreased,3,16358693
0,22.0,Anaemia,2,16358696
0,22.0,Chronic kidney disease,5,16358698
0,22.0,Renal impairment,6,16358699
0,22.0,Interstitial lung disease,2,16358700
1,22.0,Diarrhoea,2,16358700
2,22.0,Anaemia,2,16358700
3,22.0,White blood cell count decreased,2,16358700
4,22.0,Thrombocytopenia,2,16358700
0,22.0,Metastases to lymph nodes,6,16358715
1,22.0,Drug intolerance,6,16358715
2,22.0,Fluid retention,6,16358715
3,22.0,Breast cancer metastatic,6,16358715
4,22.0,Malignant neoplasm progression,6,16358715
5,22.0,Scar,6,16358715
6,22.0,Weight increased,6,16358715
7,22.0,Carpal tunnel syndrome,6,16358715
0,22.0,Dysaesthesia pharynx,1,16358724
0,22.0,Contusion,1,16358726
1,22.0,Dyspnoea,1,16358726
2,22.0,Asthenia,1,16358726
3,22.0,Visual field defect,1,16358726
0,22.0,Hypertensive crisis,6,16358730
1,22.0,Hypertension,1,16358730
2,22.0,Proteinuria,6,16358730
0,22.0,Female genital tract fistula,3,16358736
0,22.0,Deep vein thrombosis,2,16358737
1,22.0,Drug ineffective,3,16358737
2,22.0,Dyspnoea,6,16358737
3,22.0,Pulmonary embolism,2,16358737
4,22.0,Phlebitis,3,16358737
0,22.0,Death,5,16358776
1,22.0,Inappropriate schedule of product administration,6,16358776
0,22.1,Fatigue,1,16358816
1,22.1,Tooth development disorder,6,16358816
2,22.1,General physical health deterioration,1,16358816
3,22.1,Venous thrombosis limb,1,16358816
4,22.1,Diarrhoea,1,16358816
0,22.0,Non-small cell lung cancer recurrent,6,16358861
1,22.0,Metastases to liver,3,16358861
2,22.0,Malignant neoplasm progression,3,16358861
3,22.0,Spinal compression fracture,6,16358861
4,22.0,Scar,6,16358861
0,22.0,Bone marrow failure,1,16358883
0,22.0,Anxiety,6,16358910
1,22.0,Emotional distress,6,16358910
2,22.0,Impaired quality of life,6,16358910
3,22.0,Alopecia,2,16358910
4,22.0,Pain,6,16358910
0,22.0,Alopecia,2,16358911
1,22.0,Psychological trauma,6,16358911
0,22.1,Alopecia,3,16358913
1,22.1,Psychological trauma,6,16358913
0,22.0,Malignant neoplasm progression,3,16358945
1,22.0,Pericardial effusion,3,16358945
0,22.1,Alopecia,2,16358958
0,22.0,Alopecia,6,16358987
0,22.0,Psychological trauma,6,16359000
1,22.0,Alopecia,2,16359000
0,22.0,Psychological trauma,6,16359001
1,22.0,Alopecia,2,16359001
0,22.0,Alopecia,3,16359013
1,22.0,Psychological trauma,6,16359013
0,22.0,Psychological trauma,6,16359017
1,22.0,Alopecia,2,16359017
0,22.0,Alopecia,6,16359073
1,22.0,Psychological trauma,6,16359073
0,22.0,Psychological trauma,6,16359079
1,22.0,Alopecia,3,16359079
0,22.0,Psychological trauma,6,16359116
1,22.0,Alopecia,2,16359116
0,22.0,Alopecia,2,16359124
0,22.1,Psychological trauma,6,16359127
1,22.1,Alopecia,2,16359127
0,22.0,Neoplasm recurrence,1,16359318
1,22.0,Therapeutic product effect incomplete,6,16359318
0,22.0,Vascular device infection,1,16359336
0,22.1,Malignant neoplasm progression,5,16359356
1,22.1,Interstitial lung disease,5,16359356
0,22.0,Gastric cancer,3,16359361
0,22.0,Liver injury,6,16359362
0,22.0,Malignant neoplasm progression,6,16359400
0,22.0,Heart rate increased,6,16359412
1,22.0,Hyperhidrosis,6,16359412
2,22.0,Lip oedema,6,16359412
3,22.0,Blood pressure decreased,6,16359412
4,22.0,Asthenia,6,16359412
5,22.0,Face oedema,6,16359412
6,22.0,Conjunctival hyperaemia,6,16359412
0,22.1,Vomiting,2,16359420
1,22.1,Pruritus,6,16359420
2,22.1,Death,5,16359420
3,22.1,Malignant neoplasm progression,6,16359420
4,22.1,Dyspnoea,6,16359420
5,22.1,Pneumonitis,6,16359420
6,22.1,Pneumonia,6,16359420
7,22.1,Diarrhoea,2,16359420
8,22.1,Flushing,6,16359420
0,22.0,Band sensation,2,16359454
1,22.0,Hypotension,2,16359454
0,22.0,Agranulocytosis,1,16359548
1,22.0,Leukopenia,1,16359548
0,22.0,Off label use,6,16359551
1,22.0,Disease progression,6,16359551
2,22.0,Intentional product use issue,6,16359551
0,22.0,Atypical femur fracture,6,16359579
1,22.0,Atypical femur fracture,1,16359579
0,22.0,Ill-defined disorder,6,16359585
1,22.0,Chills,6,16359585
2,22.0,Hypotension,6,16359585
0,22.0,Cardiac dysfunction,6,16359608
1,22.0,Gastrointestinal disorder,6,16359608
2,22.0,Pelvic fluid collection,6,16359608
3,22.0,Prostatitis,6,16359608
4,22.0,Bone disorder,6,16359608
5,22.0,Cholesterosis,6,16359608
6,22.0,Renal cyst,6,16359608
0,22.1,Vesical fistula,6,16359612
1,22.1,Off label use,6,16359612
2,22.1,Peritonitis,6,16359612
3,22.1,Intentional product use issue,6,16359612
0,22.0,Liver injury,2,16359615
0,22.1,Pancreatic enlargement,2,16359636
1,22.1,Drug-induced liver injury,2,16359636
2,22.1,Kidney enlargement,2,16359636
0,22.0,Ejection fraction decreased,1,16359649
1,22.0,Cardiotoxicity,1,16359649
0,22.0,Off label use,6,16359656
1,22.0,Haematotoxicity,6,16359656
2,22.0,Intentional product use issue,6,16359656
0,22.0,Tumour marker increased,6,16359657
1,22.0,Ascites,6,16359657
2,22.0,Metastases to peritoneum,6,16359657
3,22.0,Malaise,6,16359657
4,22.0,Nausea,6,16359657
0,22.0,Bone marrow failure,6,16359700
1,22.0,Fatigue,6,16359700
2,22.0,Impaired healing,1,16359700
3,22.0,Bone pain,6,16359700
0,22.0,Intestinal obstruction,1,16359706
0,22.0,Paraesthesia,1,16359759
1,22.0,Thrombocytopenia,1,16359759
2,22.0,Iron deficiency,3,16359759
3,22.0,Myalgia,1,16359759
4,22.0,Hypersensitivity,1,16359759
5,22.0,Febrile neutropenia,2,16359759
6,22.0,Fatigue,3,16359759
7,22.0,Bone pain,1,16359759
8,22.0,Musculoskeletal pain,1,16359759
9,22.0,Neutropenia,1,16359759
10,22.0,Stoma site haemorrhage,3,16359759
0,22.0,Bladder cancer recurrent,3,16359783
0,22.0,Pneumonitis,6,16359817
0,22.0,Leukopenia,1,16359838
1,22.0,Agranulocytosis,1,16359838
0,22.0,Agranulocytosis,1,16359845
0,22.0,Neutropenic sepsis,2,16359914
0,22.0,Asthenia,5,16359958
1,22.0,Metastases to bone,6,16359958
2,22.0,Pleural effusion,6,16359958
3,22.0,Prostatic specific antigen increased,6,16359958
4,22.0,Failure to thrive,5,16359958
5,22.0,Prostate cancer,6,16359958
6,22.0,Dyspnoea,1,16359958
0,22.0,Malignant neoplasm progression,6,16359963
1,22.0,Pleural effusion,2,16359963
0,22.1,Intestinal obstruction,2,16360015
0,22.0,Decreased appetite,6,16360017
1,22.0,Neutrophil count decreased,6,16360017
2,22.0,Alopecia,6,16360017
3,22.0,Proteinuria,6,16360017
4,22.0,Hepatic encephalopathy,6,16360017
0,22.0,Malignant neoplasm progression,3,16360110
1,22.0,Metastases to bone,3,16360110
0,22.0,Aspartate aminotransferase increased,1,16360132
1,22.0,Alanine aminotransferase increased,1,16360132
0,22.0,Nausea,3,16360138
1,22.0,Fatigue,3,16360138
0,22.0,Cardiac disorder,5,16360177
0,22.1,Liver disorder,2,16360233
1,22.1,Cholangitis sclerosing,2,16360233
2,22.1,Pneumonia,1,16360233
0,22.0,Thrombocytopenia,2,16360276
0,22.1,Electrocardiogram QT prolonged,3,16360282
1,22.1,Restlessness,1,16360282
0,22.0,Appendicitis noninfective,6,16360300
1,22.0,Haemoglobin decreased,6,16360300
2,22.0,Occult blood positive,6,16360300
3,22.0,Haematochezia,6,16360300
4,22.0,Dizziness,6,16360300
0,22.0,Drug ineffective,6,16360308
1,22.0,Metastases to bone,6,16360308
0,22.0,Oesophagitis,6,16360408
0,22.0,Malaise,1,16360431
1,22.0,Loss of consciousness,1,16360431
2,22.0,Tachycardia,1,16360431
3,22.0,Hyperthermia,1,16360431
0,22.0,Aortitis,1,16360469
0,22.0,Rectal haemorrhage,3,16360479
0,22.0,Coronary arterial stent insertion,6,16360503
0,22.0,Incontinence,6,16360532
0,22.0,Tumour ulceration,6,16360548
1,22.0,Tumour cavitation,6,16360548
0,22.0,Adrenal insufficiency,6,16360562
0,22.0,Fulminant type 1 diabetes mellitus,1,16360563
0,22.0,Asthenia,2,16360589
1,22.0,Dyspepsia,2,16360589
2,22.0,Decreased appetite,2,16360589
3,22.0,Fatigue,2,16360589
0,22.0,Skin lesion,6,16360626
1,22.0,Dermatitis allergic,6,16360626
0,22.0,Neutropenia,1,16360637
0,22.0,Hypoxia,5,16360639
1,22.0,Oropharyngeal pain,1,16360639
2,22.0,Asthenia,1,16360639
3,22.0,Malignant neoplasm progression,5,16360639
4,22.0,Cardiac failure,5,16360639
5,22.0,Personality change,1,16360639
6,22.0,Decreased appetite,1,16360639
7,22.0,Hypotension,5,16360639
8,22.0,Myocardial infarction,6,16360639
9,22.0,Pleural effusion,6,16360639
10,22.0,Hypoaesthesia,1,16360639
11,22.0,Vomiting,1,16360639
12,22.0,Confusional state,1,16360639
13,22.0,General physical health deterioration,6,16360639
14,22.0,Weight decreased,1,16360639
0,22.0,Blood albumin abnormal,,16360642
1,22.0,Ascites,,16360642
2,22.0,Hepatic function abnormal,,16360642
3,22.0,Eastern Cooperative Oncology Group performance status worsened,,16360642
4,22.0,General physical health deterioration,,16360642
5,22.0,Weight decreased,,16360642
6,22.0,Alpha 1 foetoprotein increased,,16360642
7,22.0,Blood pressure increased,1,16360642
8,22.0,Blood bilirubin increased,,16360642
9,22.0,Oedema peripheral,,16360642
10,22.0,Diarrhoea,,16360642
0,22.0,Hepatic enzyme increased,1,16360643
1,22.0,Hepatocellular injury,1,16360643
0,22.0,Neuropathy peripheral,6,16360656
0,22.0,Decreased appetite,6,16360659
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16360659
2,22.0,Bone marrow toxicity,6,16360659
3,22.0,Treatment noncompliance,6,16360659
4,22.0,Asthenia,6,16360659
5,22.0,Neuropathy peripheral,6,16360659
6,22.0,Protein urine present,6,16360659
7,22.0,Renal impairment,6,16360659
0,22.0,Pulmonary embolism,5,16360684
0,22.0,Intestinal obstruction,6,16360702
1,22.0,Death,5,16360702
0,22.0,Terminal state,6,16360704
0,22.0,Metastases to bone,6,16360720
1,22.0,Breast cancer stage IV,6,16360720
2,22.0,Malignant neoplasm progression,6,16360720
0,22.0,Terminal state,6,16360729
1,22.0,Prostate cancer,6,16360729
0,22.0,Liver disorder,6,16360738
1,22.0,Hepatitis acute,2,16360738
0,22.0,Optic disc hyperaemia,6,16360740
1,22.0,Blindness transient,6,16360740
0,22.0,Respiratory failure,5,16360742
1,22.0,Product use in unapproved indication,6,16360742
0,22.0,Fall,6,16360750
0,22.0,Product size issue,6,16360763
1,22.0,Product solubility abnormal,6,16360763
2,22.0,Retching,6,16360763
3,22.0,Malignant neoplasm progression,6,16360763
4,22.0,Product use complaint,6,16360763
5,22.0,Chest discomfort,6,16360763
6,22.0,Cough,6,16360763
0,22.0,Loss of consciousness,6,16360820
1,22.0,Hallucination,6,16360820
2,22.0,Recurrent cancer,6,16360820
3,22.0,Infection,6,16360820
4,22.0,Hypophagia,6,16360820
5,22.0,Intestinal obstruction,6,16360820
6,22.0,Dysgeusia,6,16360820
7,22.0,Unevaluable event,2,16360820
8,22.0,Weight abnormal,1,16360820
9,22.0,Fatigue,2,16360820
10,22.0,Malnutrition,1,16360820
0,22.0,Hypercalcaemia,1,16360838
1,22.0,Interstitial lung disease,2,16360838
2,22.0,Blood creatinine increased,1,16360838
0,22.0,Toxic neuropathy,6,16360855
1,22.0,Neurotoxicity,6,16360855
0,22.0,Urine odour abnormal,3,16360905
1,22.0,Muscle spasms,3,16360905
2,22.0,Dyspnoea,3,16360905
3,22.0,Cardiac output decreased,3,16360905
4,22.0,Renal impairment,3,16360905
5,22.0,Abdominal pain upper,3,16360905
6,22.0,Blood test abnormal,3,16360905
7,22.0,Oedema,3,16360905
0,22.0,Hepatitis,3,16360921
0,22.0,Dyspepsia,6,16360933
1,22.0,Amenorrhoea,6,16360933
2,22.0,Neuropathy peripheral,3,16360933
3,22.0,Colorectal cancer stage III,1,16360933
4,22.0,Mucous stools,6,16360933
5,22.0,Carpal tunnel syndrome,3,16360933
6,22.0,Cognitive disorder,3,16360933
7,22.0,Tendonitis,3,16360933
8,22.0,Abdominal discomfort,6,16360933
9,22.0,Abdominal pain upper,6,16360933
0,22.1,Death,5,16360938
1,22.1,Cognitive disorder,6,16360938
2,22.1,Asthenia,6,16360938
0,22.0,Death,5,16360973
0,22.0,Neoplasm,6,16360974
1,22.0,Tumour marker increased,6,16360974
2,22.0,Rash,6,16360974
3,22.0,Malignant neoplasm progression,6,16360974
4,22.0,Fatigue,6,16360974
0,22.0,Radiation pneumonitis,2,16360994
0,22.0,Sepsis,,16361019
0,22.0,Death,5,16361033
0,22.0,Death,5,16361052
0,22.0,Haemoptysis,6,16361082
0,22.0,Neoplasm progression,6,16361110
0,22.0,Escherichia infection,,16361159
1,22.0,Urinary tract infection bacterial,,16361159
2,22.0,Confusional state,,16361159
3,22.0,Clostridium difficile infection,,16361159
0,22.0,Acute kidney injury,,16361170
1,22.0,Transfusion,,16361170
2,22.0,Colitis,,16361170
3,22.0,Respiratory failure,,16361170
4,22.0,Septic shock,,16361170
5,22.0,Multiple organ dysfunction syndrome,,16361170
6,22.0,Coagulopathy,,16361170
7,22.0,Ejection fraction decreased,,16361170
8,22.0,Sinus tachycardia,,16361170
9,22.0,Renal tubular necrosis,,16361170
10,22.0,Acidosis,,16361170
0,22.1,Tooth abscess,2,16361264
1,22.1,Large intestine polyp,1,16361264
2,22.1,Haemoptysis,2,16361264
3,22.1,Bone disorder,2,16361264
4,22.1,Swelling face,2,16361264
5,22.1,Cardiac disorder,2,16361264
6,22.1,Blood pressure increased,2,16361264
7,22.1,Palpitations,2,16361264
0,22.0,Cardiac arrest,5,16361273
0,22.0,Joint swelling,3,16361280
1,22.0,Dehydration,1,16361280
2,22.0,Blood pressure increased,2,16361280
0,22.1,Adrenal insufficiency,2,16361282
1,22.1,Hypothyroidism,2,16361282
2,22.1,Diarrhoea,2,16361282
3,22.1,Psoriasis,2,16361282
4,22.1,Malignant neoplasm progression,5,16361282
0,22.0,Hypotension,2,16361346
1,22.0,Band sensation,2,16361346
0,22.1,Thyroiditis,6,16361349
1,22.1,Secondary adrenocortical insufficiency,6,16361349
2,22.1,Staphylococcal infection,6,16361349
3,22.1,Bone marrow failure,6,16361349
0,22.0,Diarrhoea,3,16361355
1,22.0,Renal failure,3,16361355
2,22.0,Hypoglycaemia,3,16361355
3,22.0,Mineral metabolism disorder,3,16361355
4,22.0,Hypotension,3,16361355
0,22.0,Paraneoplastic syndrome,,16361356
0,22.0,Hypotension,1,16361357
1,22.0,Decreased appetite,4,16361357
0,22.0,Lung disorder,3,16361360
0,22.0,Pulse absent,,16361367
1,22.0,Cyanosis,,16361367
2,22.0,Unresponsive to stimuli,,16361367
0,22.1,Ejection fraction decreased,3,16361377
1,22.1,Cardiac failure,2,16361377
0,22.0,Inappropriate schedule of product administration,6,16361394
1,22.0,Death,5,16361394
2,22.0,Product use in unapproved indication,6,16361394
0,22.0,Wrong technique in product usage process,6,16361424
1,22.0,Hyperhidrosis,6,16361424
0,22.0,Product dose omission,6,16361434
1,22.0,No adverse event,6,16361434
0,22.0,Diarrhoea,,16361451
1,22.0,Gastritis,,16361451
2,22.0,Feeling abnormal,,16361451
3,22.0,Malaise,,16361451
4,22.0,Blood electrolytes decreased,,16361451
5,22.0,Depressed level of consciousness,,16361451
0,22.0,Madarosis,3,16361459
1,22.0,Alopecia,3,16361459
2,22.0,Hair disorder,3,16361459
3,22.0,Hair texture abnormal,3,16361459
0,22.0,Alopecia,2,16361472
1,22.0,Madarosis,3,16361472
2,22.0,Hair texture abnormal,3,16361472
3,22.0,Hair disorder,3,16361472
0,22.0,Alopecia,6,16361478
1,22.0,Lymphocyte count increased,6,16361478
2,22.0,Fatigue,6,16361478
3,22.0,Depression,6,16361478
4,22.0,Blood count abnormal,6,16361478
5,22.0,Infection susceptibility increased,6,16361478
6,22.0,White blood cell count decreased,3,16361478
0,22.0,Musculoskeletal stiffness,3,16361486
1,22.0,Fatigue,6,16361486
2,22.0,Alopecia,3,16361486
0,22.0,Neoplasm progression,6,16361492
0,22.0,Memory impairment,6,16361508
0,22.0,White blood cell count decreased,6,16361511
0,22.1,Joint swelling,2,16361523
1,22.1,Malignant pleural effusion,6,16361523
2,22.1,Second primary malignancy,6,16361523
3,22.1,Agranulocytosis,6,16361523
4,22.1,Chest pain,3,16361523
0,22.0,Respiratory failure,5,16361566
0,22.0,Hepatotoxicity,2,16361634
0,22.1,Movement disorder,3,16361654
1,22.1,Malignant neoplasm progression,5,16361654
2,22.1,Hepatic function abnormal,6,16361654
3,22.1,Lung disorder,1,16361654
4,22.1,Metastases to central nervous system,5,16361654
5,22.1,Somnolence,3,16361654
0,22.0,Incorrect dose administered,6,16361663
1,22.0,No adverse event,6,16361663
0,22.0,Death,,16361703
0,22.0,Cerebrovascular accident,6,16361711
0,22.0,Alopecia,6,16361715
1,22.0,Anaemia,6,16361715
2,22.0,Leukopenia,6,16361715
3,22.0,Neuropathy peripheral,6,16361715
4,22.0,Neutropenia,6,16361715
0,22.0,Breast cancer recurrent,2,16361726
1,22.0,Injection site discomfort,6,16361726
0,22.1,Blood count abnormal,6,16361793
0,22.0,Dry skin,6,16361797
0,22.0,Neutropenia,1,16361799
1,22.0,Fatigue,3,16361799
2,22.0,Musculoskeletal pain,1,16361799
3,22.0,Iron deficiency,3,16361799
4,22.0,Neutropenia,1,16361799
5,22.0,Paraesthesia,1,16361799
6,22.0,Myalgia,1,16361799
7,22.0,Hypersensitivity,1,16361799
8,22.0,Paraesthesia,1,16361799
9,22.0,Myalgia,1,16361799
10,22.0,Febrile neutropenia,2,16361799
11,22.0,Bone pain,1,16361799
12,22.0,Thrombocytopenia,1,16361799
13,22.0,Stoma site haemorrhage,3,16361799
0,22.1,Pruritus,6,16361814
1,22.1,Myalgia,1,16361814
2,22.1,Oedema,6,16361814
3,22.1,Asthenia,6,16361814
4,22.1,Neoplasm recurrence,6,16361814
5,22.1,Mass,6,16361814
6,22.1,Lacrimation increased,6,16361814
7,22.1,Oral mucosal eruption,6,16361814
0,22.0,Neoplasm progression,6,16361820
0,22.0,Full blood count decreased,6,16361823
0,22.0,Neoplasm progression,6,16361826
0,22.0,White blood cell count decreased,6,16361829
0,22.0,Neoplasm progression,6,16361836
1,22.0,Visual impairment,6,16361836
0,22.0,Neoplasm recurrence,3,16361837
0,22.0,Headache,6,16361843
1,22.0,Nausea,6,16361843
2,22.0,Stiff leg syndrome,3,16361843
3,22.0,Pain in extremity,3,16361843
4,22.0,Gait disturbance,3,16361843
0,22.0,Rheumatoid factor positive,,16361845
1,22.0,Arthritis,,16361845
2,22.0,Disability,,16361845
3,22.0,Injury,,16361845
4,22.0,Asthenia,,16361845
5,22.0,Deformity,,16361845
6,22.0,Gait disturbance,,16361845
7,22.0,Pain,,16361845
0,22.1,Dizziness,4,16361889
1,22.1,Vaginal infection,4,16361889
2,22.1,Anal fissure,1,16361889
3,22.1,Pain,6,16361889
4,22.1,Haematoma,1,16361889
5,22.1,Alopecia,1,16361889
6,22.1,Decreased appetite,1,16361889
7,22.1,Fatigue,4,16361889
8,22.1,Hypokinesia,1,16361889
9,22.1,Abdominal pain,1,16361889
10,22.1,Diarrhoea,1,16361889
11,22.1,Anaemia,1,16361889
12,22.1,Hot flush,1,16361889
13,22.1,Epistaxis,1,16361889
14,22.1,Polyneuropathy,1,16361889
15,22.1,Post-traumatic pain,3,16361889
16,22.1,Neutropenia,1,16361889
17,22.1,Vascular device infection,6,16361889
18,22.1,Swelling,6,16361889
19,22.1,Dyspnoea,4,16361889
0,22.0,Decreased appetite,1,16361900
1,22.0,Pyrexia,1,16361900
2,22.0,Somnolence,1,16361900
0,22.0,Haematotoxicity,6,16361939
1,22.0,Metastases to pelvis,6,16361939
2,22.0,Liver disorder,6,16361939
0,22.0,Cystitis,3,16361963
0,22.0,Neoplasm progression,6,16362011
0,22.0,Fatigue,6,16362027
1,22.0,Nausea,6,16362027
0,22.0,Neutropenia,6,16362047
0,22.1,Urticaria,1,16362110
1,22.1,Rash,1,16362110
2,22.1,Product dose omission,1,16362110
0,22.0,Headache,6,16362115
1,22.0,Dizziness,6,16362115
2,22.0,Vomiting,6,16362115
3,22.0,Cough,6,16362115
4,22.0,Dyspnoea,6,16362115
5,22.0,Death,5,16362115
6,22.0,Asthenia,6,16362115
0,22.0,Diarrhoea,,16362218
1,22.0,Skin exfoliation,,16362218
2,22.0,Colon cancer metastatic,,16362218
3,22.0,Eastern Cooperative Oncology Group performance status worsened,,16362218
4,22.0,Dysphonia,,16362218
0,22.0,Renal impairment,,16362219
1,22.0,Malignant urinary tract neoplasm,,16362219
0,22.0,Off label use,,16362222
1,22.0,Benign neoplasm of adrenal gland,,16362222
2,22.0,Pulmonary mass,1,16362222
3,22.0,Decreased appetite,1,16362222
4,22.0,Diarrhoea,1,16362222
5,22.0,Fatigue,1,16362222
0,22.0,Femur fracture,3,16362223
0,22.0,Gastric ulcer perforation,5,16362231
0,22.0,Ejection fraction decreased,6,16362234
1,22.0,Contraindicated product administered,6,16362234
0,22.0,Thrombocytopenia,6,16362235
1,22.0,Proteinuria,6,16362235
2,22.0,Neutropenia,6,16362235
3,22.0,Hypertension,6,16362235
0,22.0,Sudden death,5,16362236
0,22.0,Malaise,6,16362237
1,22.0,Proteinuria,6,16362237
2,22.0,Neutropenia,6,16362237
3,22.0,Peripheral sensory neuropathy,6,16362237
4,22.0,Nausea,6,16362237
5,22.0,Anaemia,6,16362237
6,22.0,Alopecia,6,16362237
7,22.0,Thrombocytopenia,6,16362237
8,22.0,Peripheral motor neuropathy,6,16362237
0,22.0,Ejection fraction decreased,6,16362247
1,22.0,Contraindicated product administered,6,16362247
0,22.0,Ejection fraction decreased,6,16362248
1,22.0,Contraindicated product administered,6,16362248
0,22.0,Cerebrovascular accident,5,16362264
0,22.0,Contraindicated product administered,6,16362266
1,22.0,Ejection fraction decreased,6,16362266
0,22.0,Contraindicated product administered,6,16362273
1,22.0,Ejection fraction decreased,6,16362273
0,22.0,Orthostatic hypotension,1,16362278
0,22.0,Cystoid macular oedema,2,16362279
0,22.0,Blindness,1,16362281
0,22.0,Cerebral haematoma,4,16362328
1,22.0,Cerebral venous thrombosis,4,16362328
0,22.0,Sleep disorder,3,16362331
1,22.0,Disturbance in attention,3,16362331
0,22.0,Loss of personal independence in daily activities,6,16362333
0,22.0,White blood cell count decreased,6,16362353
0,22.0,Eating disorder,6,16362362
1,22.0,Extra dose administered,6,16362362
2,22.0,Feeling hot,6,16362362
0,22.0,Pain in extremity,1,16362372
1,22.0,Abdominal pain upper,6,16362372
2,22.0,Diarrhoea,6,16362372
3,22.0,Arthropathy,1,16362372
0,22.0,Red blood cell count decreased,6,16362380
1,22.0,White blood cell count decreased,6,16362380
2,22.0,Spinal disorder,6,16362380
3,22.0,Fatigue,3,16362380
0,22.0,Arthralgia,3,16362399
0,22.1,Maximal voluntary ventilation abnormal,6,16362593
1,22.1,Off label use,6,16362593
2,22.1,Myopathy toxic,6,16362593
3,22.1,Muscle fatigue,6,16362593
4,22.1,Dyspnoea,6,16362593
5,22.1,Mitochondrial toxicity,6,16362593
6,22.1,Muscle injury,6,16362593
0,22.0,Arthritis,3,16362617
1,22.0,Hypothyroidism,3,16362617
2,22.0,Hepatitis,1,16362617
3,22.0,Autoimmune pancreatitis,1,16362617
4,22.0,Pancreatic mass,1,16362617
0,22.0,White blood cell count decreased,3,16362622
0,22.0,Malignant neoplasm progression,6,16362649
1,22.0,Platelet count decreased,2,16362649
2,22.0,Nausea,3,16362649
3,22.0,Neutrophil count decreased,2,16362649
0,22.0,Death,5,16362673
1,22.0,Adverse drug reaction,,16362673
2,22.0,Skin exfoliation,,16362673
3,22.0,Radiotherapy,,16362673
4,22.0,Vocal cord paralysis,,16362673
5,22.0,Asthenia,,16362673
6,22.0,Pain in extremity,,16362673
7,22.0,Urine output decreased,,16362673
8,22.0,Decreased activity,6,16362673
9,22.0,Feeding disorder,,16362673
10,22.0,Erythema,,16362673
11,22.0,Dysphonia,,16362673
12,22.0,Mucosal inflammation,,16362673
13,22.0,Dysphagia,,16362673
14,22.0,Oral candidiasis,,16362673
15,22.0,Off label use,,16362673
16,22.0,Fatigue,3,16362673
17,22.0,Drug intolerance,,16362673
18,22.0,Gait disturbance,,16362673
19,22.0,Weight decreased,,16362673
20,22.0,Fluid intake reduced,,16362673
21,22.0,Alopecia,,16362673
22,22.0,Adverse drug reaction,6,16362673
0,22.0,Disease progression,6,16362676
1,22.0,Metastases to central nervous system,5,16362676
0,22.0,Diarrhoea,1,16362677
1,22.0,Death,5,16362677
2,22.0,Off label use,6,16362677
3,22.0,Hospice care,6,16362677
4,22.0,Metastases to central nervous system,6,16362677
5,22.0,Breast cancer stage IV,6,16362677
0,22.0,Hypogeusia,6,16362678
1,22.0,Abdominal pain upper,6,16362678
2,22.0,Decreased appetite,6,16362678
3,22.0,Weight decreased,6,16362678
4,22.0,Diarrhoea,3,16362678
5,22.0,Vomiting,3,16362678
6,22.0,Dehydration,6,16362678
7,22.0,Nausea,3,16362678
8,22.0,Hysterectomy,6,16362678
9,22.0,Stomatitis,6,16362678
0,22.1,Cholangitis,1,16362710
1,22.1,Anxiety disorder,6,16362710
2,22.1,Neuropathy peripheral,6,16362710
3,22.1,Thyroid disorder,2,16362710
4,22.1,Malignant neoplasm progression,6,16362710
0,22.0,Coronary artery bypass,1,16362717
0,22.0,Interstitial lung disease,1,16362728
1,22.0,Metastases to central nervous system,6,16362728
0,22.0,Lung disorder,2,16362729
1,22.0,Stevens-Johnson syndrome,1,16362729
0,22.0,Liver abscess,3,16362867
0,22.0,Radiation pneumonitis,6,16362877
0,22.0,Malignant neoplasm progression,6,16362898
1,22.0,Breast cancer metastatic,6,16362898
0,22.0,Nausea,6,16362903
1,22.0,Fatigue,6,16362903
0,22.0,Fatigue,6,16362908
0,22.0,Feeding disorder,6,16362916
1,22.0,Off label use,,16362916
0,22.0,Death,5,16362950
0,22.1,Memory impairment,6,16363044
1,22.1,Blood cholesterol increased,6,16363044
2,22.1,Cognitive disorder,6,16363044
3,22.1,Arthralgia,6,16363044
4,22.1,Pneumonia,6,16363044
5,22.1,Neoplasm progression,6,16363044
6,22.1,Lipids increased,6,16363044
7,22.1,Weight increased,6,16363044
0,22.0,Malignant neoplasm progression,6,16363058
1,22.0,Malignant pleural effusion,1,16363058
0,22.0,Hypertension,,16363062
1,22.0,Pulmonary embolism,5,16363062
2,22.0,Dyspnoea,,16363062
0,22.0,Lung cancer metastatic,5,16363073
1,22.0,Electrocardiogram QT prolonged,1,16363073
0,22.0,Renal disorder,2,16363074
0,22.0,Headache,6,16363101
1,22.0,Diarrhoea,6,16363101
2,22.0,Nausea,6,16363101
3,22.0,Alopecia,6,16363101
0,22.0,Arthralgia,1,16363208
1,22.0,Myalgia,1,16363208
0,22.0,Iron deficiency,6,16363209
1,22.0,Insomnia,6,16363209
2,22.0,Vaginal haemorrhage,6,16363209
0,22.0,Cerebrovascular accident,,16363210
0,22.0,Pulmonary embolism,2,16363272
0,22.0,Death,5,16363280
1,22.0,Pleural effusion,6,16363280
2,22.0,Asthenia,6,16363280
3,22.0,Decreased appetite,6,16363280
4,22.0,Vomiting,6,16363280
0,22.0,Cardiac disorder,6,16363408
1,22.0,Arteriospasm coronary,6,16363408
0,22.0,Tendon disorder,3,16363468
0,22.0,Respiratory failure,2,16363478
1,22.0,Interstitial lung disease,2,16363478
0,22.0,Foot fracture,6,16363508
0,22.0,Eosinophilic colitis,1,16363509
1,22.0,Stomatitis,1,16363509
2,22.0,Diarrhoea,1,16363509
0,22.0,Diarrhoea,6,16363517
1,22.0,General physical health deterioration,6,16363517
2,22.0,Cellulitis,6,16363517
3,22.0,Hypocalcaemia,6,16363517
0,22.0,Acute kidney injury,1,16363546
1,22.0,Medication error,6,16363546
2,22.0,Overdose,1,16363546
0,22.0,Dementia,3,16363548
1,22.0,Depression,3,16363548
0,22.1,Depression,6,16363641
1,22.1,Abdominal pain,3,16363641
2,22.1,Peripheral swelling,3,16363641
3,22.1,Anaemia,6,16363641
4,22.1,Neuropathy peripheral,6,16363641
5,22.1,Blood calcium decreased,6,16363641
6,22.1,Dizziness,6,16363641
7,22.1,Product dose omission,6,16363641
8,22.1,Constipation,3,16363641
9,22.1,Blood magnesium decreased,3,16363641
10,22.1,Fatigue,6,16363641
11,22.1,Somnolence,6,16363641
0,22.0,Gastrointestinal necrosis,6,16363700
1,22.0,Ischaemia,6,16363700
2,22.0,Acute abdomen,6,16363700
3,22.0,Intestinal ischaemia,5,16363700
4,22.0,Abdominal pain,6,16363700
0,22.0,Eye haemorrhage,6,16363701
1,22.0,Vision blurred,6,16363701
2,22.0,Thrombocytopenia,3,16363701
3,22.0,Muscle spasms,3,16363701
4,22.0,Wheezing,6,16363701
5,22.0,Epistaxis,3,16363701
6,22.0,Insomnia,6,16363701
7,22.0,Cough,2,16363701
8,22.0,Faeces soft,6,16363701
9,22.0,Mood swings,3,16363701
10,22.0,Product dose omission,6,16363701
11,22.0,Fatigue,3,16363701
12,22.0,Contusion,6,16363701
13,22.0,Decreased activity,6,16363701
14,22.0,Back pain,3,16363701
0,22.1,Decreased immune responsiveness,1,16363703
0,22.1,Fatigue,1,16363714
1,22.1,Sinus bradycardia,1,16363714
2,22.1,Sinus bradycardia,1,16363714
3,22.1,Malaise,1,16363714
0,22.0,Myocardial infarction,1,16363737
0,22.0,Renal impairment,3,16363759
1,22.0,Blood potassium increased,1,16363759
2,22.0,Acute kidney injury,3,16363759
0,22.0,Product use issue,6,16363760
0,22.0,Hypotension,6,16363779
1,22.0,Pleural effusion,6,16363779
2,22.0,Death,5,16363779
3,22.0,Off label use,6,16363779
4,22.0,Pyrexia,6,16363779
5,22.0,Overdose,6,16363779
0,22.0,Acute kidney injury,1,16363792
1,22.0,Colitis,1,16363792
2,22.0,Diarrhoea,1,16363792
0,22.0,Infection,1,16363795
1,22.0,Pyrexia,1,16363795
2,22.0,C-reactive protein increased,1,16363795
0,22.0,Death,5,16363800
1,22.0,Vomiting,1,16363800
2,22.0,Bone pain,6,16363800
0,22.0,Immune-mediated enterocolitis,6,16363802
1,22.0,Haemoptysis,6,16363802
2,22.0,Acute respiratory failure,1,16363802
3,22.0,Pneumothorax,5,16363802
4,22.0,Pneumonitis,3,16363802
0,22.0,Nausea,2,16363817
1,22.0,Depressed mood,6,16363817
2,22.0,Tumour marker decreased,6,16363817
3,22.0,Neutropenia,1,16363817
4,22.0,Electrocardiogram QT prolonged,1,16363817
5,22.0,Arthralgia,6,16363817
6,22.0,Hepatic lesion,6,16363817
7,22.0,Weight decreased,6,16363817
8,22.0,Liver function test abnormal,1,16363817
9,22.0,Abdominal pain upper,6,16363817
10,22.0,Tumour marker increased,6,16363817
0,22.0,Renal pain,6,16363821
1,22.0,Oropharyngeal pain,6,16363821
2,22.0,Decreased immune responsiveness,3,16363821
3,22.0,Decreased appetite,2,16363821
4,22.0,Blood acid phosphatase increased,3,16363821
5,22.0,Red blood cell count increased,3,16363821
6,22.0,Gastrointestinal disorder,3,16363821
7,22.0,Nausea,2,16363821
8,22.0,Red blood cell count decreased,2,16363821
9,22.0,Pain,6,16363821
10,22.0,Alanine aminotransferase increased,3,16363821
11,22.0,Back pain,6,16363821
12,22.0,Headache,2,16363821
13,22.0,Poisoning,3,16363821
14,22.0,Urinary incontinence,3,16363821
15,22.0,White blood cell count decreased,3,16363821
16,22.0,Platelet count decreased,2,16363821
17,22.0,Depressed mood,2,16363821
18,22.0,Bone pain,6,16363821
19,22.0,Bronchospasm,3,16363821
20,22.0,Productive cough,3,16363821
21,22.0,Aspartate aminotransferase increased,3,16363821
22,22.0,Mean cell volume increased,3,16363821
23,22.0,Feeling abnormal,6,16363821
24,22.0,Bone disorder,6,16363821
25,22.0,Social anxiety disorder,3,16363821
26,22.0,Dizziness,3,16363821
27,22.0,Cough,3,16363821
28,22.0,Transaminases increased,3,16363821
29,22.0,Drug-induced liver injury,3,16363821
30,22.0,Drug intolerance,2,16363821
0,22.0,Psychomotor skills impaired,1,16363851
1,22.0,Somnolence,1,16363851
2,22.0,Poverty of speech,1,16363851
3,22.0,Memory impairment,1,16363851
0,22.0,Hypoxia,2,16363858
1,22.0,Biopsy lung abnormal,2,16363858
2,22.0,Product use issue,2,16363858
3,22.0,Therapeutic response decreased,2,16363858
4,22.0,Computerised tomogram thorax abnormal,2,16363858
5,22.0,Respiratory failure,2,16363858
6,22.0,Bronchial polyp,2,16363858
7,22.0,Multifocal micronodular pneumocyte hyperplasia,2,16363858
8,22.0,Pulmonary oedema,2,16363858
9,22.0,Organising pneumonia,2,16363858
0,22.0,Computerised tomogram thorax abnormal,2,16363859
1,22.0,Biopsy lung abnormal,2,16363859
2,22.0,Bronchial polyp,2,16363859
3,22.0,Multifocal micronodular pneumocyte hyperplasia,2,16363859
4,22.0,Product use issue,2,16363859
5,22.0,Therapeutic response decreased,2,16363859
6,22.0,Organising pneumonia,2,16363859
7,22.0,Respiratory failure,2,16363859
8,22.0,Pulmonary oedema,2,16363859
9,22.0,Hypoxia,2,16363859
0,22.0,Malignant neoplasm progression,6,16363860
1,22.0,Breast cancer,6,16363860
0,22.0,Alopecia,1,16363896
1,22.0,Ocular hyperaemia,1,16363896
2,22.0,Neoplasm progression,6,16363896
0,22.0,Bone marrow failure,6,16363900
0,22.0,Death,5,16363902
1,22.0,Diarrhoea,1,16363902
2,22.0,Nausea,1,16363902
3,22.0,Pyrexia,1,16363902
0,22.0,Mouth swelling,6,16363903
1,22.0,Rash,6,16363903
2,22.0,Lip swelling,6,16363903
0,22.0,Dyspnoea exertional,6,16363906
1,22.0,Chest pain,6,16363906
0,22.0,C-reactive protein increased,2,16363913
1,22.0,Oropharyngeal pain,6,16363913
2,22.0,Aspartate aminotransferase increased,2,16363913
3,22.0,Interstitial lung disease,2,16363913
0,22.0,Pulmonary mass,6,16363943
1,22.0,Rash,2,16363943
2,22.0,Neoplasm progression,6,16363943
3,22.0,Paronychia,2,16363943
4,22.0,Otitis externa,6,16363943
0,22.0,Circumstance or information capable of leading to medication error,6,16363953
1,22.0,Product dose omission,6,16363953
0,22.0,Malignant neoplasm progression,6,16363967
1,22.0,Proteinuria,2,16363967
0,22.0,Neutropenia,1,16363968
1,22.0,Leukopenia,1,16363968
0,22.0,Internal haemorrhage,1,16363972
1,22.0,Decreased appetite,1,16363972
2,22.0,Malignant neoplasm progression,6,16363972
3,22.0,Pallor,1,16363972
4,22.0,Weight decreased,1,16363972
5,22.0,Fatigue,1,16363972
0,22.0,Back injury,6,16363973
0,22.0,Death,5,16363975
1,22.0,Renal failure,6,16363975
2,22.0,Neutropenia,6,16363975
0,22.0,Parkinson^s disease,6,16363978
0,22.0,Dehydration,6,16363980
1,22.0,Diarrhoea,6,16363980
0,22.0,Diplopia,6,16363987
1,22.0,Second primary malignancy,6,16363987
2,22.0,Pituitary tumour,6,16363987
3,22.0,Malaise,6,16363987
4,22.0,Headache,6,16363987
5,22.0,Neoplasm progression,6,16363987
0,22.0,Colitis ulcerative,6,16363988
1,22.0,Diarrhoea,1,16363988
2,22.0,Rash,1,16363988
3,22.0,Fatigue,6,16363988
4,22.0,Nausea,3,16363988
0,22.0,Neoplasm progression,5,16363990
1,22.0,Dehydration,6,16363990
2,22.0,White blood cell count decreased,6,16363990
3,22.0,Asthenia,6,16363990
0,22.0,Leukopenia,1,16364066
1,22.0,Neoplasm progression,6,16364066
2,22.0,Cardiac disorder,6,16364066
3,22.0,Anaemia,1,16364066
4,22.0,Pulmonary embolism,6,16364066
5,22.0,Pruritus,6,16364066
0,22.0,Acute respiratory failure,2,16364067
0,22.1,Interstitial lung disease,5,16364070
1,22.1,Multiple organ dysfunction syndrome,5,16364070
0,22.0,Seizure,6,16364078
0,22.0,Dyspnoea,3,16364080
1,22.0,Interstitial lung disease,2,16364080
2,22.0,Chronic obstructive pulmonary disease,2,16364080
3,22.0,Pulmonary hypertension,1,16364080
4,22.0,Oedema peripheral,2,16364080
5,22.0,Lower respiratory tract infection,3,16364080
6,22.0,Pleural effusion,2,16364080
0,22.0,Death,5,16364081
0,22.1,Generalised oedema,1,16364149
0,22.0,Euthanasia,5,16364173
0,22.0,Nausea,6,16364195
1,22.0,Diarrhoea,6,16364195
